HP17, a new pigment-like antibiotic produced by a new strain of Spirillospora

Related Experiment Videos

H Hacéne1, G Lefebvre

  • 1Laboratoire de Microbiologie Appliquée, Unité de Recherche sur les Zones Arides, Université des Sciences et de la Technologie H. Boumediéne, Alger-Gare, Algeria.

The Journal of Applied Bacteriology
|May 1, 1996
PubMed

Insights

A novel red pigment antibiotic, designated HP17, was isolated from Spirillospora strain 719. This compound, distinct from spirillomycin, shows potential as a new antimicrobial agent.

Area of Science:

  • Microbiology
  • Natural Products Chemistry
  • Pharmacology

Background:

  • Spirillospora species are known producers of bioactive compounds.
  • Antibiotic discovery is crucial for combating microbial resistance.

Purpose of the Study:

  • To isolate and characterize a novel antibiotic pigment produced by Spirillospora strain 719.
  • To compare the novel compound with previously identified antibiotics from related strains.

Main Methods:

  • Extraction of the red pigment using methanol from mycelium and fermentation broth.
  • Purification via Thin-Layer Chromatography (TLC) and High-Performance Liquid Chromatography (HPLC).
  • Characterization using UV absorption spectrum and physicochemical properties.

Main Results:

  • A deep red pigment, designated HP17, was successfully extracted and purified.
  • HP17's characteristics place it within the Berdy et al. classification system (3.3.2.2.8).
  • HP17 shares similarities with spirillomycin but differs in molecular weight and chemical nature.

Conclusions:

  • Spirillospora strain 719 produces a unique antibiotic pigment, HP17.
  • HP17 represents a potentially new class of antibiotics with distinct chemical properties.
  • Further investigation into HP17's antimicrobial activity and structure is warranted.

Related Concept Videos